Skip to content
Home/Companies/Biotech/ICD Therapeutics

ICD Therapeutics

Biotech·Germany·Exited 2019
Entry
Hold
Exit
2019

Who owns ICD Therapeutics?

ICD Therapeutics was owned by Boehringer Ingelheim Venture Fund through Boehringer Ingelheim Venture Fund (2010 vintage), exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-08-31

Boehringer Ingelheim Venture Fund
Investor
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund · 2010 · Evergreen

Key facts

HQGermany
SectorBiotech
StatusAcquired
Exit Type
Trade Sale
Buyer
MOIC
Exit Year
2019
Track ICD Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy ICD Therapeutics?

6 strategic and 114financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on ICD Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue